These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 36468020)

  • 41. A Novel Ferroptosis-Related Gene Model for Overall Survival Predictions of Bladder Urothelial Carcinoma Patients.
    Zhang M; Zhang X; Yu M; Zhang W; Zhang D; Zeng S; Wang X; Hu X
    Front Oncol; 2021; 11():698856. PubMed ID: 34386423
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A novel focal adhesion-related risk model predicts prognosis of bladder cancer -- a bioinformatic study based on TCGA and GEO database.
    Hu J; Wang L; Li L; Wang Y; Bi J
    BMC Cancer; 2022 Nov; 22(1):1158. PubMed ID: 36357874
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characterization of an Autophagy-Immune Related Genes Score Signature and Prognostic Model and its Correlation with Immune Response for Bladder Cancer.
    Yu J; Mao W; Sun S; Hu Q; Wang C; Xu Z; Liu R; Chen S; Xu B; Chen M
    Cancer Manag Res; 2022; 14():67-88. PubMed ID: 35023971
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Characterization of hazard infiltrating immune cells and relative risk genes in bladder urothelial carcinoma.
    Lv Y; Jin P; Chen Z; Zhang P
    Am J Transl Res; 2020; 12(11):7510-7527. PubMed ID: 33312386
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of Immune-Related Genes Associated With Bladder Cancer Based on Immunological Characteristics and Their Correlation With the Prognosis.
    Kang Z; Li W; Yu YH; Che M; Yang ML; Len JJ; Wu YR; Yang JF
    Front Genet; 2021; 12():763590. PubMed ID: 34899848
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification and Validation of the Prognostic Stemness Biomarkers in Bladder Cancer Bone Metastasis.
    Kang Y; Zhu X; Wang X; Liao S; Jin M; Zhang L; Wu X; Zhao T; Zhang J; Lv J; Zhu D
    Front Oncol; 2021; 11():641184. PubMed ID: 33816287
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identifying M1 Macrophage-Related Genes Through a Co-expression Network to Construct a Four-Gene Risk-Scoring Model for Predicting Thyroid Cancer Prognosis.
    Zhuang G; Zeng Y; Tang Q; He Q; Luo G
    Front Genet; 2020; 11():591079. PubMed ID: 33193731
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prognostic Signature Development on the Basis of Macrophage Phagocytosis-Mediated Oxidative Phosphorylation in Bladder Cancer.
    Qu G; Xu Y; Lu Z; Nie H; Tang C; Hou J; Wen X
    Oxid Med Cell Longev; 2022; 2022():4754935. PubMed ID: 36211821
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identifying a hypoxia related score to predict the prognosis of bladder cancer: a study with The Cancer Genome Atlas (TCGA) database.
    Zhang Z; Li Q; Li A; Wang F; Li Z; Meng Y; Zhang Q
    Transl Androl Urol; 2021 Dec; 10(12):4353-4364. PubMed ID: 35070817
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification of a novel signature based on unfolded protein response-related gene for predicting prognosis in bladder cancer.
    Zhu K; Xiaoqiang L; Deng W; Wang G; Fu B
    Hum Genomics; 2021 Dec; 15(1):73. PubMed ID: 34930465
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical neutrophil-associated genes as reliable predictors of hepatocellular carcinoma.
    Song L; Xu C; Zhang T; Chen S; Hu S; Cheng B; Tong H; Li X
    Front Genet; 2022; 13():989779. PubMed ID: 36276937
    [No Abstract]   [Full Text] [Related]  

  • 52. Comprehensive Exploration of Tumor Microenvironment Modulation Based on the ESTIMATE Algorithm in Bladder Urothelial Carcinoma Microenvironment.
    Chen J; Lv B; Zhan Y; Zhu K; Zhang R; Chen B; Jin Y; Li Y; Zheng J; Lin C
    Front Oncol; 2022; 12():724261. PubMed ID: 35237505
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Integrative transcriptional characterization of cell cycle checkpoint genes promotes clinical management and precision medicine in bladder carcinoma.
    Shi WW; Guan JZ; Long YP; Song Q; Xiong Q; Qin BY; Ma ZQ; Hu Y; Yang B
    Front Oncol; 2022; 12():915662. PubMed ID: 36033441
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characterization of the basement membrane in kidney renal clear cell carcinoma to guide clinical therapy.
    Xiong X; Chen C; Yang J; Ma L; Wang X; Zhang W; Yuan Y; Peng M; Li L; Luo P
    Front Oncol; 2022; 12():1024956. PubMed ID: 36439501
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A comprehensive analysis of FBN2 in bladder cancer: A risk factor and the tumour microenvironment influencer.
    Lu Z; Lu Z; Lai Y; Zhou H; Li Z; Cai W; Xu Z; Luo H; Chen Y; Li J; Zhang J; He Z; Tang F
    IET Syst Biol; 2023 Aug; 17(4):162-173. PubMed ID: 37337404
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification of five long noncoding RNAs signature and risk score for prognosis of bladder urothelial carcinoma.
    Zhang C; Li Z; Hu J; Qi F; Li X; Luo J
    J Cell Biochem; 2020 Jan; 121(1):856-866. PubMed ID: 31373406
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Establishment and Validation of a Tumor Microenvironment Prognostic Model for Predicting Bladder Cancer Survival Status Based on Integrated Bioinformatics Analyses.
    Chen Q; Yin G; He X; Jiang T; Zhou H; Wu Y; Li Y
    Evid Based Complement Alternat Med; 2022; 2022():4351005. PubMed ID: 36225190
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tumor Microenvironment Analysis Identified Subtypes Associated With the Prognosis and the Tumor Response to Immunotherapy in Bladder Cancer.
    Zhang H; Song J; Dong J; Liu Z; Lin L; Wang B; Ma Q; Ma L
    Front Genet; 2021; 12():551605. PubMed ID: 33732281
    [No Abstract]   [Full Text] [Related]  

  • 59. A novel survival model based on a Ferroptosis-related gene signature for predicting overall survival in bladder cancer.
    Liang Y; Ye F; Xu C; Zou L; Hu Y; Hu J; Jiang H
    BMC Cancer; 2021 Aug; 21(1):943. PubMed ID: 34418989
    [TBL] [Abstract][Full Text] [Related]  

  • 60. RNA-Sequencing Data Reveal a Prognostic Four-lncRNA-Based Risk Score for Bladder Urothelial Carcinoma: An in Silico Update.
    He RQ; Huang ZG; Li TY; Wei YP; Chen G; Lin XG; Wang QY
    Cell Physiol Biochem; 2018; 50(4):1474-1495. PubMed ID: 30359990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.